BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10727398)

  • 1. Phosphorylation of Oct-2 at sites located in the POU domain induces differential down-regulation of Oct-2 DNA-binding ability.
    Pevzner V; Kraft R; Kostka S; Lipp M
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):29-35. PubMed ID: 10727398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream activation of a TATA-less promoter by Oct-2, Bob1, and NF-kappaB directs expression of the homing receptor BLR1 to mature B cells.
    Wolf I; Pevzner V; Kaiser E; Bernhardt G; Claudio E; Siebenlist U; Förster R; Lipp M
    J Biol Chem; 1998 Oct; 273(44):28831-6. PubMed ID: 9786883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression.
    Wang J; Yen A
    Mol Cell Biol; 2004 Mar; 24(6):2423-43. PubMed ID: 14993281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter.
    Nakshatri H; Nakshatri P; Currie RA
    J Biol Chem; 1995 Aug; 270(33):19613-23. PubMed ID: 7642649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical characterization of the Oct-2 POU domain with implications for bipartite DNA recognition.
    Botfield MC; Jancso A; Weiss MA
    Biochemistry; 1992 Jun; 31(25):5841-8. PubMed ID: 1610826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5.
    Legler DF; Loetscher M; Roos RS; Clark-Lewis I; Baggiolini M; Moser B
    J Exp Med; 1998 Feb; 187(4):655-60. PubMed ID: 9463416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
    Babb R; Cleary MA; Herr W
    Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of expression of chemokine receptor BLR1/CXCR5 during B cell maturation.
    Pevzner V; Wolf I; Burgstahler R; Förster R; Lipp M
    Curr Top Microbiol Immunol; 1999; 246():79-84; discussion 85. PubMed ID: 10396042
    [No Abstract]   [Full Text] [Related]  

  • 9. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overlapping octamer/TAATGARAT motif is a high-affinity binding site for the cellular transcription factors Oct-1 and Oct-2.
    Dent CL; Latchman DS
    Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):541-5. PubMed ID: 1650186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.
    Schreiber E; Harshman K; Kemler I; Malipiero U; Schaffner W; Fontana A
    Nucleic Acids Res; 1990 Sep; 18(18):5495-503. PubMed ID: 2216722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain.
    Cleary MA; Herr W
    Mol Cell Biol; 1995 Apr; 15(4):2090-100. PubMed ID: 7891704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins.
    Verrijzer CP; van Oosterhout JA; van der Vliet PC
    Mol Cell Biol; 1992 Feb; 12(2):542-51. PubMed ID: 1346336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Segments of the POU domain influence one another's DNA-binding specificity.
    Aurora R; Herr W
    Mol Cell Biol; 1992 Feb; 12(2):455-67. PubMed ID: 1732727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oct-1 homeo domain contacts only part of the octamer sequence and full oct-1 DNA-binding activity requires the POU-specific domain.
    Verrijzer CP; Kal AJ; van der Vliet PC
    Genes Dev; 1990 Nov; 4(11):1964-74. PubMed ID: 1980478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of the Oct-2 transcription factor RNA is differentially regulated in neuronal cells and B cells and results in protein isoforms with opposite effects on the activity of octamer/TAATGARAT-containing promoters.
    Lillycrop KA; Latchman DS
    J Biol Chem; 1992 Dec; 267(35):24960-5. PubMed ID: 1281152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter.
    Thévenin C; Lucas BP; Kozlow EJ; Kehrl JH
    J Biol Chem; 1993 Mar; 268(8):5949-56. PubMed ID: 7680653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.
    Kemler I; Bucher E; Seipel K; Müller-Immerglück MM; Schaffner W
    Nucleic Acids Res; 1991 Jan; 19(2):237-42. PubMed ID: 2014164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High mobility group I/Y protein functions as a specific cofactor for Oct-2A: mapping of interaction domains.
    Abdulkadir SA; Casolaro V; Tai AK; Thanos D; Ono SJ
    J Leukoc Biol; 1998 Nov; 64(5):681-91. PubMed ID: 9823775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human involucrin promoter activity by POU domain proteins.
    Welter JF; Gali H; Crish JF; Eckert RL
    J Biol Chem; 1996 Jun; 271(25):14727-33. PubMed ID: 8663077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.